MarkBuiMD

Physician

Dr. Bui is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Anesthesiology, 2022 - 2026
Case Western Reserve University School of MedicineClass of 2022
University of California, San DiegoBS, General Biology, 2013 - 2017

PubMed

Long-Term Visual Outcomes in Neovascular Age-Related Macular Degeneration Eyes With Baseline Macular Atrophy on Anti-Vascular Endothelial Growth Factor Treatment.
Michael J Foster, Jacqueline Shaia, Christopher M Maatouk, Catherine A Urbano, Mark T Bui
Ophthalmic Surgery, Lasers & Imaging Retina. 2023-04-01
2 citations
Trends in imaging utilization for small cell lung cancer: a decision tree analysis of the NCCN guidelines.
Elias Kikano, Sree Harsha Tirumani, Chong Hyun Suh, Jonathan M Gan, Thomas Bomberger
Clinical Imaging. 2021-07-01
Role of Key Guidelines in an Era of Precision Oncology: A Primer for the Radiologist
Jonathan M Gan, Elias Kikano, Daniel A. Smith, Mark T. Bui, Sree Harsha Tirumani
AJR. American Journal of Roentgenology. 2021-01-27

Abstracts/Posters

Impact of Baseline Macular Atrophy on Long-Term Outcomes in Neovascular Age-Related Macular Degeneration
Bui MT, Hom GL, Iyer A, Kalur A, Muste J, Singh RP, Talcott KE, Investigative Ophthalmology & Visual Science, 6/2021
Anti-VEGF Treatment Outcomes in Exudative Age-Related Macular Degeneration with Five Years or Longer Treatment in Routine Clinical Practice
Hom GL, Bui MT, Chen AX, Conti T, Greenlee TE, Singh RP, Investigative Ophthalmology & Visual Science, 6/2020